Psychiatry Research: Neuroimaging
Volume 173, Issue 2 , Pages 135-142, 30 August 2009

Neural response to lidocaine in healthy subjects

  • Bryon Adinoff

      Affiliations

    • Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States
    • VA North Texas Health Care System, Dallas, TX, United States
    • Corresponding Author InformationCorresponding author. 5323 Harry Hines Blvd., Dallas, TX 75390-8564, United States. Tel.: +1 214 645 6975; fax: +1 214 645 6976.
  • ,
  • Michael D. Devous Sr.

      Affiliations

    • Nuclear Medicine Center and Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, United States
  • ,
  • Donald C. Cooper

      Affiliations

    • Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States
  • ,
  • Susan E. Best

      Affiliations

    • Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States
    • VA North Texas Health Care System, Dallas, TX, United States
  • ,
  • Thomas S. Harris

      Affiliations

    • Nuclear Medicine Center and Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, United States
  • ,
  • Mark J. Williams

      Affiliations

    • Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States

Received 19 May 2008; received in revised form 24 February 2009; accepted 4 March 2009.

Abstract 

Recent studies suggest that some of cocaine's central nervous system (CNS) effects may be mediated through its sodium channel inhibiting local anesthetic properties. Local anesthetics that lack cocaine's strong affinity for the dopamine transporter (DAT) also produce sensory and mood effects, further suggesting a role for this neural pathway. Due to an absence of affinity at the DAT, the local anesthetic lidocaine may offer the potential to assess sodium channel activity in vivo in humans. To assess the utility of lidocaine as a CNS probe, we determined regional cerebral blood flow (rCBF) with single photon emission computed tomography (SPECT) following the intravenous administration of lidocaine (0.5 mg/kg) and compared this response to procaine (0.5 mg/kg and 1.0 mg/kg), a local anesthetic with partial affinity for the DAT, and saline. Infusions were administered in nine healthy female controls over a 10-day period with at least 2 days between each scan. Increased rCBF was observed following lidocaine, relative to saline, in the insula, caudate, thalamus, and posterior cingulate. Decreased rCBF was detected in a different region of the posterior cingulate. In general, increases in rCBF were more marked following lidocaine relative to procaine. Mood and sensory changes following lidocaine were limited and significantly less than those induced by either dose of procaine. There were no significant changes in blood pressure or heart rate following either medication. These findings suggest that lidocaine can be safely used to assess sodium channel function in persons with addictive and other psychiatric disorders.

Keywords: Tomography, Emission computed, Single photon, Lidocaine, Humans, Anesthetics, Local, Procaine, Limbic system, Basal ganglia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0925-4927(09)00060-2

doi:10.1016/j.pscychresns.2009.03.001

Psychiatry Research: Neuroimaging
Volume 173, Issue 2 , Pages 135-142, 30 August 2009